<DOC>
	<DOCNO>NCT03008746</DOCNO>
	<brief_summary>Pseudomonas aeruginosa ( PA ) associate chronic lung infection patient chronic obstructive pulmonary disease ( COPD ) . Commensal flora ( microbiota ) lung recently describe use high-throughput sequencing technique ( NGS ) . PA strain isolate lung infection episode severe COPD patient often show resistance antibiotic include imipenem mainly due mutation oprD . In collaboration Harvard Medical School , investigator recently demonstrate PA OprD mutant show increase survival ( fitness ) virulence . This bacterium could likely colonize . Colonization PA OprD mutant could influence pulmonary microbiota may worsen disease evolution , particularly term frequency exacerbation . Our objective describe modification pulmonary microbiota associate PA colonization , include OprD PA mutant , severe COPD patient . The investigator correlate microbiota modification medical history . Stable severe COPD patient include . Three group patient sample : 1 ) PA colonize , 2 ) PA colonize 3 ) PA OprD mutant colonize . Medical history record physician usual three sample perform : 1 ) sputum , 2 ) oral wash 3 ) water use oral wash . Regular bacterial culture perform NGS perform also characterize microbiota .</brief_summary>
	<brief_title>Pulmonary Microbiota Patients With Chronic Obstructive Pulmonary Disease Colonized With P. Aeruginosa Resistant Imipenem</brief_title>
	<detailed_description>Patients : Severe COPD Patients ( FEV/Forced vital capacity ( FVC ) &lt; 70 % FEV &lt; 50 % bronchodilation ) hospitalize pulmonology Department Reims Teaching Hospital . At inclusion , patient stable . Inclusion 20 patient need 100 patient total require 24 months.The study associate factor colonization PA PA mutant OprD perform patient know PA carrier . Microbiota characterization perform patient colonize PA non PA colonize patient randomly select . The analysis PA colonization influence COPD evolution do 12 month sample patient include . Evaluation criterion : - Presence P. aeruginosa resistance imipenem ( OprD mutation ) - Pulmonary microbiota : Determination bacterial load ( total number bacterium ) bacterial community diversity . Then , Opertional Taxonomic Unit ( OTU ) relative abundance analyze phylum , class , order family level . - Factors associate colonization PA PA mutant OprD : antibiotic , corticosteroid , hospitalization year precede inclusion , severity COPD , respiratory symptom cough expectoration , exertional dyspnea assess questionnaire modify Respiratory Medical Council ( MMRC ) , co-morbidities . - PA port Influence PA mutant OprD change 12 month : number exacerbation , severity exacerbation , number hospitalization , quality life assess St George 's respiratory questionnaire , death , evolution ventilatory disorder obstructive . Investigation : - Proposal participation eligible patient pulmonology consultation - If participation acceptance ( sign inform consent form ) : 3 bacteriological sample : Sputum ( usually do ) , oral wash water washing ( make specifically study ) . No change patient 's medical care ( treatment , monitoring , etc ... ) . Clinical Data Collection : criterion COPD , pulmonary function , dyspnea sputum symptom , assess MMRC scale , quality life assess St George 's respiratory questionnaire , antibiotic therapy hospitalization previous 12 month . Revaluation 12 month sample part regular monitoring patient ( idem previously ) . All sample send clinical laboratory bacteriology ( CHU Reims ) usually do sample : separation sample 2 part : 1 part store -80 ° C 1 part commonly analyze . Then , patient classify PA PA non colonize base sputum analysis . Mutation oprD characterize second step classify patient PA PA OprD mutant carrier . Samples patient colonize PA non PA colonize patient randomly select stored -80°C send `` PEGASE '' plateform Institut Pasteur de Lille . Characterization pulmonary microbiota perform high-throughput sequencing Illumina `` MiSeq '' allow reach 24 million read 2x300 bp paired-end .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Imipenem</mesh_term>
	<criteria>Severe COPD Patients ( FEV/FVC &lt; 70 % FEV &lt; 50 % bronchodilation ) hospitalize pulmonology Department Reims Teaching Hospital . patient agree participate study . patient affiliate social security scheme . patient &lt; 18yo patient protected law .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>